Neumora Therapeutics (NMRA) Shares Outstanding (2022 - 2026)
Neumora Therapeutics (NMRA) recorded Shares Outstanding of 185.16 million in Q2 2026, up 14.5% from 161.69 million a year earlier and up 2.9% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Shares Outstanding (2022 - 2026) Analysis & Trends
For FY2025, Neumora Therapeutics reported Shares Outstanding of 163.39 million, up 2.5% from FY2024.
- Annual Shares Outstanding has increased for three straight years, with a three-year compound annual growth rate of 81.8% (FY2022 to FY2025).
- Across earlier years, Shares Outstanding came in at 159.38 million in FY2024 (+145.1%), 65.02 million in FY2023 (+139.0%) and 27.21 million in FY2022.
- The Q2 2026 figure is the highest quarterly Shares Outstanding in data going back to Q3 2022.
- On a year-over-year basis, Shares Outstanding has increased for 12 consecutive quarters, with growth averaging 52.6% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding ranged from 1.4% (Q3 2025) to 439.5% (Q1 2024).
- Per Business Quant, the preceding three quarters came in at 179.87 million (Q1 2026), 163.39 million (Q4 2025) and 161.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Neumora Therapeutics | 129.65 Mn | 129.65 Mn | - | 185.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 185.16 Mn |
| Mar 31, 2026 | 179.87 Mn |
| Dec 31, 2025 | 163.39 Mn |
| Sep 30, 2025 | 161.84 Mn |
| Jun 30, 2025 | 161.69 Mn |
| Mar 31, 2025 | 161.45 Mn |
| Dec 31, 2024 | 159.38 Mn |
| Sep 30, 2024 | 159.58 Mn |
| Jun 30, 2024 | 158.98 Mn |
| Mar 31, 2024 | 157.94 Mn |
| Dec 31, 2023 | 65.02 Mn |
| Sep 30, 2023 | 46.69 Mn |
| Jun 30, 2023 | 30.13 Mn |
| Mar 31, 2023 | 29.28 Mn |
| Dec 31, 2022 | 27.21 Mn |
| Sep 30, 2022 | 27.65 Mn |
API Access
Neumora Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();